Tecfidera Generic Granted Tentative FDA Approval as Patent Assault Continues

The latest generic entry comes on the heels of a new report from ICER, which published a list of prescription drugs that had substantial price increases in 2017 and 2018 without what they consider to be new supporting evidence.

Source link

Related posts

Brainfoods has launched its first products: MindmeĀ® Drinks


Synthetic aperture magnetometry and excess kurtosis mapping of Magnetoencephalography (MEG) is predictive of epilepsy surgical outcome in a large pediatric cohort.


NSAIDs ineffective for treatment or prevention of Alzheimer's disease


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy